ERYKINE 40000 IU INJECTION

Erykine 40000 IU injection combines active ingredients like Recombinant human-derived erythropoietin a/e. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication helps treat anaemia due to chronic kidney diseases (CKD), chemotherapy for cancer, or HIV treatment using zidovudine. It also decreases the need for transfusions of red blood cells in those at risk of blood loss as a result of planned surgery and other surgical procedures.
Erykine 40000 IU injections should not be administered to patients suffering from excessive hypertension or one of the components thereof, microangiopathy thrombotic active (TMA) or purified red cell aplasia (PRCA) and seizures that are uncontrolled and pregnancy or lactation. It is also recommended to use it carefully in patients with a history of blood clots, heart disease, kidney disease,e, stroke thalassemia, liver disease, sickle-cell anaemia,  syndrome, leukaemia or c; leukaemia is not recommended to use for children who are under the age of 18 in cases where the benefits are more significant than the risk. Older patients must be monitored closely for any adverse effects. Before you begin this treatment, it’s crucial to consult your physician regarding the dangers and benefits of the Erykine 40000 IU injection.